Latest 10-Q quarterly reports

Aeva Technologies (AEVA) filed its Q2 2026 10-Q, revealing a significant increase in professional services revenue but continued operating losses and a substantial cash burn, raising concerns about future liquidity.

Lyell Immunopharma's Q2 2026 report shows continued net losses and operating expenses, though progress is noted in its CAR T-cell therapy development for LBCL and mCRC.

Alpha Teknova's Q2 2026 Form 10-Q reveals an 18.5% revenue increase to $12.2 million, but operating losses widened due to higher sales and marketing expenses.

MBIA Inc. filed its Q2 2026 10-Q, detailing continued net losses and ongoing legal battles, particularly concerning the PREPA restructuring, while also noting a slight improvement in statutory capital for its subsidiaries.

MetaVia Inc. reported increased R&D expenses and a widening net loss for Q2 2026, while acknowledging substantial doubt about its ability to continue as a going concern.

Arlo Technologies Inc. announced a significant increase in total revenue and gross profit for the second quarter of 2026, driven by subscription growth and strategic acquisitions.

NextCure, Inc. reported its Q2 2026 results, detailing a significant net loss and substantial doubt about its going concern status, while simultaneously announcing a proposed merger with Avere Therapeutics and a comprehensive restructuring plan.

Cloudflare, Inc. filed its Form 10-Q for the period ended June 30, 2026, reporting increased revenue but also significant net losses and substantial restructuring charges related to an AI-first operating model evolution.

vTv Therapeutics Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting $36.8 million in revenue driven by licensing agreements, but also significant operating losses and a substantial accumulated deficit.

Plexus Corp. announced a significant increase in net sales for the third quarter of fiscal year 2026, driven by robust performance across key market sectors and geographic regions.

Post Holdings reported a 2% decrease in net sales for the third quarter, with operating profit down 19%, though year-to-date performance shows growth.

RE/MAX Holdings, Inc. reported a 5.8% decrease in total revenue to $68.5 million and a net loss attributable to the company of $4.3 million for the second quarter of 2026.

Vaxart, Inc. reported a net loss of $13.5 million for Q2 2026, with a significant reduction in government contract revenue and continued operational expenses, alongside its delisting from Nasdaq.

Surrozen, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing progress in its Wnt pathway modulation platform for ophthalmology and reporting a net loss.

First Northwest Bancorp reported stable net interest income and a slight increase in total assets for Q2 2026, while managing deposit costs and navigating legal challenges.

Pulse Biosciences, Inc. reported its Q2 2026 results, highlighting progress in cardiac device development while continuing to incur significant operating losses and relying on equity financing.

Amprius Technologies Inc. announced a significant increase in revenue for the second quarter of 2026, driven by strong sales of its SiCore batteries, though the company continues to operate at a net loss.

Lionsgate Studios Corp. reported a substantial increase in Q1 FY27 revenue, primarily fueled by strong performance in its Motion Picture segment, while Television Production saw a decline.

World Acceptance Corporation announced a substantial increase in net income and operating income for the first quarter ended June 30, 2026, driven by higher revenues and reduced credit loss provisions.

Innovate Corp. reports increased revenue driven by its Infrastructure segment, but faces substantial debt, a going concern warning, and ongoing asset disposition efforts.

BioLife Solutions announced a significant merger agreement with Repligen Corporation, alongside reporting a 21% year-over-year revenue increase for the second quarter of 2026.

Enact Holdings, Inc. (ACT) reported its second quarter 2026 financial results, demonstrating steady revenue growth, increased net investment income, and robust capital reserves.

Westwood Holdings Group, Inc. announced a 10% increase in total revenues for the second quarter of 2026, driven by advisory and trust fees, alongside a significant rise in net income.

Restaurant Brands International reports a substantial increase in net income and revenue for the second quarter of 2026, driven by strong system-wide sales growth and favorable foreign exchange rates.

LifeStance Health Group, Inc. announced significant revenue increases and improved operational metrics for the second quarter of 2026, alongside ongoing efforts to address internal control deficiencies.

Microchip Technology Inc. reported a substantial increase in net sales and operating income for the first quarter ended June 30, 2026, driven by recovering demand and improved gross margins.

loanDepot, Inc. reported a net loss for the second quarter of 2026, with revenues impacted by higher interest rates, though strategic initiatives like the Figure partnership showed early gains.

AVITA Medical's Q2 2026 report shows an 18% revenue increase driven by product sales, but persistent operating losses and a significant accumulated deficit raise going concern issues.

Peabody Energy reported a net loss for the second quarter of 2026, with revenues impacted by lower volumes in key segments, though improved pricing in metallurgical coal provided some offset.

Mid Penn Bancorp, Inc. announced significant growth in net income and net interest margin for the second quarter of 2026, driven by strategic acquisitions and improved asset yields.